Walder Wyss advised the buyer in this transaction. A group of entrepreneurs advised by Nachfolgepartner AG acquires all shares in iPet.ch GmbH (iPet.ch), the largest online...
Nachfolgepartner-led Group of Investors’ Acquisition of iPet.ch GmbH
BC Platforms’ USD 20 Million Growth Financing
Walder Wyss advised BC Platforms on the deal. BC Platforms announced a USD 20m growth financing led by Jolt Capital. BC Platforms is a global leader in...
Vector BioPharma’s USD 30 Million Series A Funding Round
Walder Wyss advised Versant Ventures on the deal. Versant Ventures announced the debut of Vector BioPharma, a biopharmaceutical company developing a precision gene delivery platform that...
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
BioVersys’ CHF 24.2 Million Series C Financing Round
MLLStart! advised Clinical Research Ventures. Walder Wyss advises BioVersys. BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for...
Astorg’s Acquisition of CordenPharma
Freshfields Bruckhaus Deringer has advised International Chemical Investors Group on the deal, while Walder Wyss and Latham & Watkins advised Astorg. Milbank advised the management of...
Engimmune Therapeutics’ CHF 15.5 Million Seed Financing Round
Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings. Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led...
Cimeio Therapeutics’ $50 Million Series A Financing Round
Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics. Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel...
Kooky’s €6 Million Financing Round
Bär & Karrer advised kooky in this transaction. Walder Wyss advises UVC Partners. The start-up kooky has completed financing round of over six million Euro. In...
Memo Therapeutics’ CHF 37 Million Series B Financing Round
Walder Wyss advised Adjuvant Capital. Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B...
Alloy Therapeutics’ Acquisition of deepCDR Biologics
Walder Wyss acted as Swiss legal counsel for Alloy Therapeutics Inc on the deal. Vischer advised deepCDR Biologics AG. Alloy Therapeutics, a biotechnology ecosystem company, acquired...
GlycoEra’s CHF 45 Million Series A Financing Round
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...